Immunitor at 3rd Virtual HIV/AIDS Congress to commemorate AIDS day
Immunitor Company announces presentation of a paper ‘Mucosal AIDS
vaccines’ at the 3rd Virtual HIV/AIDS Congress which started on
internet on October 14, 2002 and closed on World AIDS day on December
1, 2002. The complete html or PDF version of the paper can be found at
http://www.aidscongress.net/article.php?id_comunicacao=143. The paper
is presented in Basic Science section. Other topics covered at this
Congress include: Social and Behavioral Science; Epidemiology,
Prevention and Public Health; Clinical Science and Care; and HIV and
Tuberculosis. This Congress is the third annual event organized by
AIDSPortugal.com – the non-profit Portuguese association SIDAnet which
unites medical professionals and social workers to provide treatment
and counseling for people with AIDS.
The presented paper summarizes as to what is the best strategy for
developing a potent AIDS vaccine since all feasible and obvious
approaches in making AIDS vaccines have been tried in past two decades
without much of success. The presentation draws attention to the fact
that new thinking and revision of prevailing dogmas needs to be in
place if we really want a vaccine. Conventional envelope-based
antibody-inducing vaccines do not appear to hold a promise and
cellular immune responses, especially those mediated by CD8
cytotoxic/suppressor (CTL) and CD4 helper T lymphocytes, seem to be
needed to control HIV. Vaccines capable of inducing cell-mediated
responses are, therefore, considered critical for controlling the
spread of HIV. DNA-based vaccines are currently thought to be an
answer but will they fulfill the promise? The review of
state-of-the-art is provided to summarize what we know and still
don’t know. The focus of the discussion is primarily on mucosal
vaccines – relatively new area in AIDS research. The update on
V-1 Immunitor, the oral AIDS vaccine produced in Thailand, is provided
within this context. The paper ended with a conclusion that without
departure from the uninspiring consensus no substantial progress in
AIDS vaccine field can be envisioned.
For reprints and further information please contact the corresponding
author Dr. Aldar S. Bourinbaiar at: immuni…@aol.com.